$42.9 Million is the total value of Blackcrane Capital, LLC's 9 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCEL | Sell | AVITA THERAPEUTICS INC | $11,951,000 | -57.5% | 474,982 | -48.5% | 27.88% | -12.4% |
| WIX | Sell | WIX.COM LTD | $10,604,000 | -33.7% | 41,610 | -33.3% | 24.74% | +36.8% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $6,369,000 | -57.7% | 124,787 | -70.9% | 14.86% | -12.7% |
| NICE | Sell | NICE LTD - SPON ADRsponsored adr | $5,892,000 | -28.7% | 25,952 | -40.6% | 13.75% | +47.1% |
| PROF | Buy | PROFOUND MEDICAL CORP | $3,474,000 | +17.0% | 196,924 | +12.3% | 8.11% | +141.2% |
| BHVN | Sell | BIOHAVEN PHARMACEUTICAL HOLD | $2,868,000 | -68.1% | 44,112 | -64.1% | 6.69% | -34.1% |
| MSFT | Sell | MICROSOFT CORP | $1,242,000 | -56.5% | 5,904 | -57.9% | 2.90% | -10.3% |
| TAK | TAKEDA PHARMACEUTIC-SP ADRsponsored ads | $459,000 | -0.4% | 25,723 | 0.0% | 1.07% | +105.6% | |
| OCX | Exit | ONCOCYTE CORP | $0 | – | -2,982,557 | -100.0% | -6.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 14 | Q4 2021 | 20.2% |
| NICE LTD - SPON ADR | 13 | Q1 2022 | 18.1% |
| TAKEDA PHARMACEUTIC-SP ADR | 13 | Q1 2022 | 19.3% |
| WIX.COM LTD | 10 | Q1 2022 | 24.7% |
| PROFOUND MEDICAL CORP | 9 | Q1 2022 | 15.6% |
| AXONICS MODULATION TECHNOLOG | 9 | Q4 2021 | 17.4% |
| AVITA THERAPEUTICS INC | 8 | Q1 2022 | 31.8% |
| BIOHAVEN PHARMACEUTICAL HOLD | 6 | Q4 2020 | 14.9% |
| VISA INC-CLASS A SHARES | 5 | Q1 2020 | 14.9% |
| HDFC BANK LTD-ADR | 5 | Q1 2022 | 21.7% |
View Blackcrane Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-10 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-12 |
View Blackcrane Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.